Van Lanschot NV (VLK)
Euronext Amsterdam · Netherlands · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 61.75 |
|---|---|
| 52-week range | 48.45 – 71.15 |
| Return, 1 month / 3 months | −10.3% / −4.1% |
| Return, 1 year / 3 years | +27.0% / +219.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 34 |
| Volatility (1 year) | 22.9% |
| Worst drawdown (1 year) | -12.9% |
| Average daily value traded | 3.06M EUR |
| Dividend yield | 6.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Van Lanschot is a Dutch private bank based in 's-Hertogenbosch. It provides private banking and wealth management services to wealthy individuals, families and entrepreneurs, helping them manage their savings, investments and estate planning. The bank also serves business clients through services that include asset management and corporate finance advice. Its activities centre on the Netherlands, with a presence in neighbouring European markets, and it operates under the Van Lanschot Kempen name for its broader banking and asset management work.
Van Lanschot NV trades under the code VLK on the Euronext Amsterdam in Netherlands, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Van Lanschot NV (VLK) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 61.75 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 22 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.0% and over the last three months it fell 4.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.5% | ||
| From 52-week high | -12.6% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.1% | ||
| 6-month return | 1.9% | ||
| 12-month return, skipping the last month | 41.6% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.9% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −10.3% |
| 3 months | −4.1% |
| 6 months | +1.9% |
| 1 year | +27.0% |
| 3 years | +219.1% |
| 5 years | +299.2% |
Signals
| 50-day / 200-day average | 66.03 / 60.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jun 2026 | EUR 0.8000 |
| 25 May 2026 | EUR 3.0000 |
| 24 Jun 2025 | EUR 1.4000 |
| 26 May 2025 | EUR 2.7500 |
| 27 May 2024 | EUR 2.0000 |
| 19 Dec 2023 | EUR 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.